NO921941D0 - Spesifikke bindingsmidler - Google Patents
Spesifikke bindingsmidlerInfo
- Publication number
- NO921941D0 NO921941D0 NO1992921941A NO921941A NO921941D0 NO 921941 D0 NO921941 D0 NO 921941D0 NO 1992921941 A NO1992921941 A NO 1992921941A NO 921941 A NO921941 A NO 921941A NO 921941 D0 NO921941 D0 NO 921941D0
- Authority
- NO
- Norway
- Prior art keywords
- human antibody
- reshaped
- specific binding
- binding agents
- plap
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898926045A GB8926045D0 (en) | 1989-11-17 | 1989-11-17 | Specific binding agents |
GB909019552A GB9019552D0 (en) | 1990-09-07 | 1990-09-07 | Specific binding agents |
PCT/GB1990/001755 WO1991007500A1 (en) | 1989-11-17 | 1990-11-14 | Specific binding agents |
Publications (3)
Publication Number | Publication Date |
---|---|
NO921941D0 true NO921941D0 (no) | 1992-05-15 |
NO921941L NO921941L (no) | 1992-05-15 |
NO303066B1 NO303066B1 (no) | 1998-05-25 |
Family
ID=26296218
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO921941A NO303066B1 (no) | 1989-11-17 | 1992-05-15 | Gjenformet menneskeantistoff med spesifisitet for human placental alkalisk fosfatase eller fragment derav |
NO980656A NO980656D0 (no) | 1989-11-17 | 1998-02-16 | Analogifremgangsmåte for fremstilling av et gjenformet menneskeantistoff eller et gjenformet menneskeantistoff-fragment til å behandle kreft |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO980656A NO980656D0 (no) | 1989-11-17 | 1998-02-16 | Analogifremgangsmåte for fremstilling av et gjenformet menneskeantistoff eller et gjenformet menneskeantistoff-fragment til å behandle kreft |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0429242B1 (no) |
JP (1) | JPH05501357A (no) |
KR (2) | KR970007782B1 (no) |
AT (1) | ATE123815T1 (no) |
AU (1) | AU652923B2 (no) |
BG (1) | BG60687B1 (no) |
CA (1) | CA2066670A1 (no) |
DE (1) | DE69020112T2 (no) |
DK (1) | DK0429242T3 (no) |
ES (1) | ES2075169T3 (no) |
FI (1) | FI922220A0 (no) |
GR (1) | GR3017407T3 (no) |
HU (1) | HUT64600A (no) |
NO (2) | NO303066B1 (no) |
RO (1) | RO110262B1 (no) |
WO (1) | WO1991007500A1 (no) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9019553D0 (en) * | 1990-09-07 | 1990-10-24 | Unilever Plc | Specific binding agents |
WO1994004679A1 (en) * | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
US6800738B1 (en) | 1991-06-14 | 2004-10-05 | Genentech, Inc. | Method for making humanized antibodies |
JP4124480B2 (ja) | 1991-06-14 | 2008-07-23 | ジェネンテック・インコーポレーテッド | 免疫グロブリン変異体 |
GB0510790D0 (en) | 2005-05-26 | 2005-06-29 | Syngenta Crop Protection Ag | Anti-CD16 binding molecules |
JP5297742B2 (ja) * | 2008-09-26 | 2013-09-25 | 株式会社青木科学研究所 | 金型用粉体含有油性潤滑剤、これを用いた静電塗布方法、及び静電塗布装置 |
US10946106B2 (en) | 2015-11-30 | 2021-03-16 | The Regents Of The University Of California | Tumor-specific payload delivery and immune activation using a human antibody targeting a highly specific tumor cell surface antigen |
EP3806894A4 (en) * | 2018-06-12 | 2022-06-08 | Promab Biotechnologies, Inc. | PLAP-CAR EFFECTIVE CELLS |
EP4286410A1 (en) | 2021-01-27 | 2023-12-06 | Innovent Biologics (Suzhou) Co., Ltd. | Single-domain antibody against cd16a and use thereof |
WO2023064928A2 (en) * | 2021-10-14 | 2023-04-20 | Arsenal Biosciences, Inc. | Immune cells having co-expressed shrnas and logic gate systems |
CN114014933B (zh) * | 2021-11-17 | 2023-05-02 | 福州迈新生物技术开发有限公司 | 抗plap蛋白单克隆抗体、细胞系及其制备方法和应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8607679D0 (en) * | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
-
1990
- 1990-11-14 EP EP90312407A patent/EP0429242B1/en not_active Expired - Lifetime
- 1990-11-14 AU AU67369/90A patent/AU652923B2/en not_active Ceased
- 1990-11-14 KR KR1019920701176A patent/KR970007782B1/ko not_active IP Right Cessation
- 1990-11-14 AT AT90312407T patent/ATE123815T1/de not_active IP Right Cessation
- 1990-11-14 WO PCT/GB1990/001755 patent/WO1991007500A1/en active IP Right Grant
- 1990-11-14 HU HU9201619A patent/HUT64600A/hu unknown
- 1990-11-14 ES ES90312407T patent/ES2075169T3/es not_active Expired - Lifetime
- 1990-11-14 CA CA002066670A patent/CA2066670A1/en not_active Abandoned
- 1990-11-14 DK DK90312407.1T patent/DK0429242T3/da active
- 1990-11-14 DE DE69020112T patent/DE69020112T2/de not_active Expired - Fee Related
- 1990-11-14 KR KR1019970700530A patent/KR970007783B1/ko not_active IP Right Cessation
- 1990-11-14 JP JP2515801A patent/JPH05501357A/ja active Pending
- 1990-11-14 RO RO92-200678A patent/RO110262B1/ro unknown
-
1992
- 1992-05-15 FI FI922220A patent/FI922220A0/fi unknown
- 1992-05-15 NO NO921941A patent/NO303066B1/no unknown
- 1992-05-15 BG BG96346A patent/BG60687B1/bg unknown
-
1995
- 1995-09-13 GR GR950402540T patent/GR3017407T3/el unknown
-
1998
- 1998-02-16 NO NO980656A patent/NO980656D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO980656D0 (no) | 1998-02-16 |
AU652923B2 (en) | 1994-09-15 |
HU9201619D0 (en) | 1992-08-28 |
KR970007783B1 (ko) | 1997-05-16 |
DK0429242T3 (da) | 1995-10-16 |
CA2066670A1 (en) | 1991-05-18 |
JPH05501357A (ja) | 1993-03-18 |
ATE123815T1 (de) | 1995-06-15 |
EP0429242A3 (en) | 1991-06-05 |
KR970007782B1 (ko) | 1997-05-16 |
FI922220A (fi) | 1992-05-15 |
HUT64600A (en) | 1994-01-28 |
DE69020112T2 (de) | 1995-11-02 |
AU6736990A (en) | 1991-06-13 |
WO1991007500A1 (en) | 1991-05-30 |
NO921941L (no) | 1992-05-15 |
EP0429242A2 (en) | 1991-05-29 |
BG60687B1 (bg) | 1995-12-29 |
KR920703837A (ko) | 1992-12-18 |
GR3017407T3 (en) | 1995-12-31 |
EP0429242B1 (en) | 1995-06-14 |
DE69020112D1 (de) | 1995-07-20 |
NO303066B1 (no) | 1998-05-25 |
ES2075169T3 (es) | 1995-10-01 |
RO110262B1 (ro) | 1995-11-30 |
FI922220A0 (fi) | 1992-05-15 |
NO980656L (no) | 1992-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE233279T1 (de) | Spezifisch bindende agentien | |
DK0429242T3 (da) | Specifikke bindingsmidler | |
PT99934A (pt) | Processo para a producao de um anticorpo anti-htnf alfa recombinante ou humanizado | |
DK25084A (da) | Human-human hybridoma mod neoplasmer | |
DK0687295T3 (da) | Human B-lymfoblastoidcellelinje, der secernerer anti-gangliosid-antistof | |
DK392387A (da) | Monoklonalt antistrof til diagnostisk anvendelse og fremgangsmaade til fremstilling af et saadan antistof | |
BG99074A (en) | Recombinant human hiv neutralizing monoclonal antibodies for prophylaxy and treatment of hiv infection | |
NO174110C (no) | Monoklonalt antistoff til anvendelse in vitro for diagnose av maligne tumor- eller akutte inflammasjonssykdommer, og som er spesifikt for N-acetyl-neuraminsyre i hybridom som produserer antistoffet | |
DE3580524D1 (de) | Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen. | |
ATE118032T1 (de) | Monoklonale antikörper und diagnoseverfahren für phytophthora-infektionen. | |
FR2697088B1 (fr) | Anticorps monoclonaux pour le diagnostic différentiel de cancers épithéliaux dans des épanchements séreux, hybridomes les secrétant et kit de diagnostic. | |
DE3787220T2 (de) | Monoklonaler Antikörper gegen menschliches Plasminogen, Verfahren zu seiner Herstellung, diesen Antikörper enthaltendes Testreagenz sowie Testsatz und diesen Antikörper produzierendes Hybridoma. | |
DK1414859T5 (da) | Monoklonale anti-SSRP-1-antistoffer og hybridomer som producerer antistofferne | |
DK182188A (da) | Humant tumorassocieret antigen |